Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02291913
Title Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists-South Fort Myers Florida 33916 United States Details
Memorial Cancer Center Hollywood Florida 33021 United States Details
Woodlands Medical Specialists Pensacola Florida 32503 United States Details
Florida Cancer Specialists-East West Palm Beach Florida 33401 United States Details
Hope Cancer Center Terre Haute Indiana 47802 United States Details
Tennessee Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field